MANGIACAPRA, FABIO
 Distribuzione geografica
Continente #
AS - Asia 4.012
NA - Nord America 598
EU - Europa 353
OC - Oceania 29
AF - Africa 2
Totale 4.994
Nazione #
SG - Singapore 3.711
US - Stati Uniti d'America 592
CN - Cina 163
IT - Italia 112
HK - Hong Kong 94
DE - Germania 55
GB - Regno Unito 50
NL - Olanda 41
CZ - Repubblica Ceca 39
AU - Australia 29
IN - India 17
FI - Finlandia 11
VN - Vietnam 8
FR - Francia 7
PL - Polonia 6
CA - Canada 5
ID - Indonesia 4
IR - Iran 4
LT - Lituania 4
RO - Romania 4
UA - Ucraina 4
AT - Austria 3
PH - Filippine 3
RS - Serbia 3
TR - Turchia 3
TW - Taiwan 3
NO - Norvegia 2
SE - Svezia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BY - Bielorussia 1
EE - Estonia 1
ES - Italia 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
KR - Corea 1
LU - Lussemburgo 1
MX - Messico 1
SI - Slovenia 1
SL - Sierra Leone 1
ZA - Sudafrica 1
Totale 4.994
Città #
Ashburn 335
Singapore 98
Hong Kong 92
Boardman 63
Rome 54
Hefei 50
London 45
Amsterdam 29
Munich 29
Brno 27
Shanghai 25
Council Bluffs 21
Perth 20
West Jordan 16
San Francisco 11
Los Angeles 10
Olomouc 10
Seattle 9
Washington 8
Bengaluru 6
Helsinki 5
New York 5
Santa Clara 5
Surat 5
Turku 5
Hanover 4
Nuremberg 4
Pune 4
Târgu Mureş 4
Xi'an 4
Zhengzhou 4
Zhoukou 4
Aubin Grove 3
Conroe 3
Dallas 3
Guangzhou 3
Melbourne 3
Milan 3
Stuttgart 3
Taipei 3
Warsaw 3
Aberdeen 2
Ankara 2
Aversa 2
Beijing 2
Belgrade 2
Bologna 2
Borås 2
Brooklyn 2
Buffalo 2
Castagnole 2
Catania 2
Ciampino 2
Durham 2
Florence 2
Greenville 2
Hamar 2
Ho Chi Minh City 2
Jinan 2
Krakow 2
Louisville 2
Mainz 2
North Bergen 2
Palermo 2
Qingdao 2
Quận Ninh Kiều 2
Ravenna 2
Shenyang 2
Shenzhen 2
Shijiazhuang 2
Sona 2
Springfield 2
Ternopil 2
The Dalles 2
Trieste 2
Xiamen 2
Xiangtan 2
Adelaide 1
Alexandria 1
Anyang 1
Ardea 1
Baguio City 1
Baoding 1
Bazhou 1
Boston 1
Budapest 1
Campagnano di Roma 1
Canberra 1
Central 1
Changzhou 1
Chicago 1
Chongqing 1
Coimbatore 1
Concord 1
Dublin 1
Freetown 1
Genoa 1
Ghent 1
Granite Falls 1
Görwihl 1
Totale 1.133
Nome #
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention 402
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element? 202
Designing the Optimal Procedure: Role of CT Scan in the Planning of Transcatheter Structural Heart Interventions 193
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 192
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 186
Current Applications and New Perspectives in Optical Coherence Tomography (OCT) Coronary Atherosclerotic Plaque Assessment: From PCI Optimization to Pharmacological Treatment Guidance 186
Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients) 181
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 177
Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention 175
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status 173
Platelet reactivity and clinical outcomes following percutaneous coronary intervention in complex higher-risk patients 166
Mid-Regional Pro-Adrenomedullin and N-Terminal Pro-B-Type Natriuretic Peptide Measurement: A Multimarker Approach to Diagnosis and Prognosis in Acute Heart Failure 160
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 160
Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study. 159
Gender-Based Specificities of Fractional Flow Reserve Measurement 153
Current management and prognosis of patients with recurrent myocardial infarction 145
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 145
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease 132
Coronary microcirculation and peri-procedural myocardial injury during elective percutaneous coronary intervention 120
Non-INvasive Functional and Anatomic vascular evaluation for the prediction of coronary artery disease: The NINFA study 92
Beyond the Calcium Score: What Additional Information from a CT Scan Can Assist in Cardiovascular Risk Assessment? 88
High value of mid-regional proadrenomedullin in COVID-19: A marker of widespread endothelial damage, disease severity, and mortality 88
Impact of endothelial dysfunction on long-term clinical outcomes in patients with chronic coronary syndromes treated with second generation drug-eluting stent implantation 87
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 86
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned? 85
Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score 84
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score 77
Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Angioplasty 76
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 75
Fractional Flow Reserve-Guided Coronary Revascularization: Evidence from Randomized and Non-Randomized Studies 74
Invasive Assessment of Coronary Microvascular Function 71
Interaction Between Diabetes Mellitus and Platelet Reactivity in Determining Long-Term Outcomes Following Percutaneous Coronary Intervention 68
Effects of ticagrelor and prasugrel on coronary microcirculation in elective percutaneous coronary intervention 67
Impact of Mediterranean diet on metabolic and inflammatory status of patients with polyvascular atherosclerotic disease 65
Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study 58
CARDIAC ANTHRACYCLINE ACCUMULATION AND B-TYPE NATRIURETIC PEPTIDE TO DEFINE RISK AND PREDICTORS OF CANCER TREATMENT RELATED EARLY DIASTOLIC DYSFUNCTION 54
Absolute coronary flow and microvascular resistance reserve in patients with severe aortic stenosis 43
In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches 40
Systematic review and meta-analysis of randomized and nonrandomized studies on fractional flow reserve-guided revascularization 35
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) 32
Impact of Chronic Kidney Disease and Platelet Reactivity on Clinical Outcomes Following Percutaneous Coronary Intervention 31
Synergistic effect of myocardial injury and mid-regional proAdrenomedullin elevation in determining clinical outcomes of SARS-CoV-2 patients 29
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 23
Impact of Tourniquet Use on Systemic Inflammatory Parameters, Functional Physical Recovery, and Cardiovascular Outcomes of Patients Undergoing Knee Arthroplasty: A Case-Control Study 21
Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis 20
Natural History of Coronary Atherosclerosis in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: The Role of Quantitative Flow Ratio 19
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study 18
Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis 13
Idiopathic sensorineural hearing loss is associated with endothelial dysfunction 12
Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development 9
Totale 5.047
Categoria #
all - tutte 16.554
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.554


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202255 0 0 2 3 0 0 0 0 0 0 7 43
2022/202369 2 2 5 9 12 0 0 3 2 0 34 0
2023/2024555 3 18 17 26 14 71 33 265 31 28 10 39
2024/20254.343 54 17 72 30 25 67 58 35 113 259 1.695 1.918
2025/202625 25 0 0 0 0 0 0 0 0 0 0 0
Totale 5.047